RayKnowChina Research Map
Shortlist

Beijing

Fu Wai Hospital

中国医学科学院阜外心血管病医院

Listed for 1 of the 61 diseases this site covers, from the research papers it led and the trials registered with it as lead sponsor or site.

Research activity in public records, not a rating of care. Whether the hospital can help a particular patient is for the hospital and the treating doctor to say.

No official website checked for this hospital yet.

Getting in touch

Research at Fu Wai Hospital

Choose a disease to see the papers and trials behind it. Each tile shows papers led, 2021–2025, and papers per year.

Only the 61 diseases this site covers. A disease it is not listed for means this hospital did not meet the listing rule for that disease in these records; it does not mean the hospital does not treat it. Which hospitals are listed

  1. Coronary heart disease冠心病2 papers led1 open trial led

Not listed for: Nasopharyngeal carcinoma, Oesophageal squamous cell carcinoma, Hepatocellular carcinoma, Stomach cancer, Lung cancer, Pancreatic cancer, Breast cancer, Glioma, Hepatoblastoma, Retinoblastoma, Chordoma, Osteosarcoma, Gastrointestinal stromal tumour, Neuroblastoma, Ewing sarcoma, Multiple myeloma, B-cell acute lymphoblastic leukaemia, Aplastic anaemia, Haemophagocytic lymphohistiocytosis, Lymphoma, Beta thalassaemia, Haemophilia A, Atypical haemolytic uraemic syndrome, Thrombotic thrombocytopenic purpura, Fanconi anaemia, Neuromyelitis optica spectrum disorder, IgG4-related disease, Myasthenia gravis, Moyamoya disease, Wilson disease, Biliary atresia, Congenital heart disease, Scoliosis, Anti-NMDA receptor encephalitis, Takayasu arteritis, Hepatic echinococcosis, Idiopathic pulmonary fibrosis, Lymphangioleiomyomatosis, Amyotrophic lateral sclerosis, Spinal muscular atrophy, Fabry disease, Pompe disease, Duchenne muscular dystrophy, Behçet disease, Alport syndrome, IgA nephropathy, Gaucher disease, Niemann–Pick disease type C, Osteogenesis imperfecta, Primary biliary cholangitis, Primary sclerosing cholangitis, Congenital diaphragmatic hernia, Hirschsprung disease, Inherited epidermolysis bullosa, Hereditary angioedema, Familial adenomatous polyposis, Leber hereditary optic neuropathy, Majeed syndrome, NGLY1 deficiency, ISG15 deficiency.

Other diseases

Coronary heart disease

冠心病

Led 2 of the 5,119 English-language PubMed papers on coronary heart disease with an author in mainland China, 2021–2025: 0.04%.

Papers led
2
2021–2025
Trials led
3
any status, ClinicalTrials.gov
Open trials led
1
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 0020212022: 0020222023: 1120232024: 0020242025: 112025

29 hospitals in Beijing for coronary heart disease231 hospitals in China for coronary heart disease

Open trials with this hospital 1

Recruiting, not yet recruiting, or by invitation on ClinicalTrials.gov on 18 Nov 2026. Trials registered only in China’s own registry (ChiCTR) are not included. Whether someone can take part is decided by the study team.

  1. Recruiting
    Risk Prediction of Disease Progression in Early-Onset Coronary Atherosclerosis
    Phase
    Not given
    Started
    2025-01
    Posted
    Registry
    NCT07316452

    Age 18 years to 45 years (registered criteria)

    Led by Fu Wai HospitalBeijing

Open in the full trial list

Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.

The records behind these numbers

Hospital name read automatically from author addresses, not yet checked by hand.

Papers it led2
  1. A Randomized Comparison of Bioheart Sirolimus-Eluting Bioresorbable Scaffold and Everolimus-Eluting Stents: The BIOHEART-II Trial.2025JACC. Cardiovascular interventionsRCT
  2. A Randomized Comparison of 2 Different Drug-Coated Balloons for In-Stent Restenosis.2023JACC. Cardiovascular interventionsRCT
All its trials on ClinicalTrials.gov, any status15
  1. Risk Prediction of Disease Progression in Early-Onset Coronary AtherosclerosisRecruitingNCT07316452Lead sponsorStart 2025-01
  2. Ticagrelor Single Antiplatelet Therapy in Patients With High Risk of Bleeding After DCB for Coronary Small Vessel DiseaseStatus unknownNCT06088433Lead sponsorPhase 4Start 2023-11
  3. XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT)CompletedNCT01178268Lead (inferred)Phase 4Start 2010-08
  4. CT Myocardial Perfusion to Guide the Diagnosis and Treatment of Patients With Stable Coronary Artery Disease (POTENTIAL)Status unknownNCT06119022Study siteN/AStart 2023-09
  5. Trial for MicroPort's Firesorb BVS: FUTURE-IIIStatus unknownNCT03660202Study siteN/AStart 2019-01
  6. The FAVOR III China StudyStatus unknownNCT03656848Study siteN/AStart 2018-12
  7. A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-IICompletedNCT02890160Study siteN/AStart 2017-08
  8. A First-in-Man Study of the Firesorb BVS (FUTURE-I)CompletedNCT02659254Study siteN/AStart 2016-01
  9. Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent® System)Status unknownNCT02448524Study sitePhase 3Start 2015-07
  10. Evaluation of New Specifications (2.25mm) of FirehawkTM in the Treatment of Coronary Heart Disease ( Firehawk_2.25 )CompletedNCT02688868Study siteN/AStart 2014-05
  11. Evaluation of New Specifications (38mm) of FirehawkTM in the Treatment of Coronary Heart DiseaseCompletedNCT02688842Study siteN/AStart 2014-05
  12. The EVOLVE China Clinical TrialCompletedNCT01966159Study siteN/AStart 2013-10
  13. Relationship Between Dosage of Clopidogrel and Platelet Aggregation in Chinese With Different GenotypeStatus unknownNCT01710436Study siteStart 2012-10
  14. Prospective, Randomized, Multicenter Trial to Assess PROMUS™ Element™ StentCompletedNCT01285999Study siteN/AStart 2011-01
  15. XIENCE V: SPIRIT WOMENCompletedNCT00496938Study sitePhase 4Start 2007-07

Run the PubMed searchClinicalTrials.gov

Getting in touch

Name card to show staff or a driver

中国医学科学院阜外心血管病医院

Fu Wai Hospital

北京

Large hospitals often have several campuses. Confirm the campus with the hospital before travelling.

Inquiry letter in English and Chinese

Fill in the brackets, then send it through the contact options on the hospital's international office or official website. Nothing typed here leaves this device.

Records hospitals usually ask for

  • A recent summary or letter from the treating doctor
  • Pathology report
  • Scans (CT, MRI, PET) with their reports, and the images if possible
  • Treatments so far, with dates
  • Current medicines

What to do next

Talk with the treating doctorThis page can be shared with the treating doctor to discuss whether this team's work is relevant.
Check the team is still therePapers lag by months and doctors move. Look for the department on the hospital's own website.
Contact the hospital directlyUse the hospital's own contacts. Hospitals never pay us, and each hospital decides which patients it accepts.

Where these numbers come from

Papers

English-language PubMed papers whose first or last author lists this hospital as their first affiliation, 2021–2025. Definitions

Trials

ClinicalTrials.gov records naming this hospital as lead sponsor or site, as of 8 Nov 2026.

Identifiers and other names

ROR
Fu Wai Hospital

Suggest a correctionDownload the data